Andreas Tiede

6.5k total citations · 2 hit papers
160 papers, 4.1k citations indexed

About

Andreas Tiede is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Andreas Tiede has authored 160 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Hematology, 38 papers in Genetics and 25 papers in Surgery. Recurrent topics in Andreas Tiede's work include Hemophilia Treatment and Research (98 papers), Platelet Disorders and Treatments (70 papers) and Blood Coagulation and Thrombosis Mechanisms (30 papers). Andreas Tiede is often cited by papers focused on Hemophilia Treatment and Research (98 papers), Platelet Disorders and Treatments (70 papers) and Blood Coagulation and Thrombosis Mechanisms (30 papers). Andreas Tiede collaborates with scholars based in Germany, United States and Austria. Andreas Tiede's co-authors include Arnold Ganser, Sonja Werwitzke, Ulrich Budde, Robert Klamroth, Jacob H. Rand, Augusto B. Federici, Claude Négrier, Craig M. Kessler, Paul Giangrande and Paul Knoebl and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Andreas Tiede

150 papers receiving 4.0k citations

Hit Papers

International recommendations on the diagnosis and treatm... 2020 2026 2022 2024 2020 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. International recommendations on the diagnosis and treatment of acquired hemophilia A
    2020 183 citations Andreas Tiede, Paul Knoebl et al. profile →
  2. Prothrombotic immune thrombocytopenia after COVID-19 vaccination
    2021 119 citations Andreas Tiede, Ulrich J. Sachs et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Tiede Germany 33 2.9k 948 688 658 353 160 4.1k
Brian Savage United States 17 2.4k 0.8× 173 0.2× 298 0.4× 654 1.0× 222 0.6× 27 3.2k
Walter H.A. Kahr Canada 30 1.3k 0.4× 228 0.2× 474 0.7× 295 0.4× 248 0.7× 94 2.5k
Andrew Dunbar United States 22 830 0.3× 487 0.5× 960 1.4× 133 0.2× 151 0.4× 55 2.0k
Michael J. Mant Canada 26 1.1k 0.4× 366 0.4× 918 1.3× 109 0.2× 114 0.3× 71 2.2k
Kousuke Marutsuka Japan 30 495 0.2× 222 0.2× 484 0.7× 516 0.8× 89 0.3× 106 2.3k
Ansgar Schulz Germany 33 1.1k 0.4× 300 0.3× 1.7k 2.5× 245 0.4× 872 2.5× 122 4.5k
Mauro Di Ianni Italy 23 632 0.2× 701 0.7× 584 0.8× 173 0.3× 150 0.4× 85 2.3k
Mitsuhiko Sugimoto Japan 23 1.0k 0.3× 138 0.1× 216 0.3× 269 0.4× 336 1.0× 54 1.5k
Masahiro Masuya Japan 26 722 0.2× 495 0.5× 768 1.1× 222 0.3× 122 0.3× 115 2.5k
Dagmar Dilloo Germany 29 1.1k 0.4× 1.5k 1.6× 1.2k 1.7× 602 0.9× 778 2.2× 92 4.7k

Countries citing papers authored by Andreas Tiede

Since Specialization
Citations

This map shows the geographic impact of Andreas Tiede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Tiede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Tiede more than expected).

Fields of papers citing papers by Andreas Tiede

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Tiede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Tiede. The network helps show where Andreas Tiede may publish in the future.

Co-authorship network of co-authors of Andreas Tiede

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Tiede. A scholar is included among the top collaborators of Andreas Tiede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Tiede. Andreas Tiede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dobbelstein, Christiane, Robert Klamroth, Christina Hart, et al.. (2025). Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A. Blood Advances. 9(22). 5853–5860.
2.
Müller, Jens, et al.. (2025). Laboratory Monitoring in Patients Receiving Emicizumab. Hämostaseologie. 1 indexed citations
3.
Alikhan, Raza, May Nour, Masahiro Yasaka, et al.. (2024). Design and rationale for REVERXaL: A real-world study of patients with factor Xa inhibitor–associated major bleeds. Thrombosis Research. 240. 109046–109046. 1 indexed citations
4.
Sachs, Ulrich J., Karolin Trautmann‐Grill, Christian Pfrepper, et al.. (2024). Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study. Research and Practice in Thrombosis and Haemostasis. 8(7). 102565–102565.
5.
Ott, Michael, et al.. (2024). A transposable element prevents severe hemophilia B and provides insights into the evolution of new- and old world primates. PLoS ONE. 19(10). e0312303–e0312303. 1 indexed citations
6.
Pfrepper, Christian, Robert Klamroth, Johannes Oldenburg, et al.. (2023). Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group. Hämostaseologie. 44(6). 466–471. 10 indexed citations
7.
Wagner, L. S., H. Schneider, Andreas Tiede, et al.. (2023). Die Anlage eines transjugulären intrahepatischen portosystemischen Shunts bei Patient:innen mit dekompensierter Leberzirrhose ist mit einer signifikanten Verbesserung der Lebensqualität assoziiert. Zeitschrift für Gastroenterologie. 61(8). e479–e480. 1 indexed citations
8.
Tiede, Andreas, et al.. (2023). von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model. Blood Advances. 7(21). 6771–6781. 2 indexed citations
9.
10.
11.
Seeliger, Benjamin, R Friedrich, Klaus Stahl, et al.. (2020). Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure. Critical Care. 24(1). 701–701. 26 indexed citations
12.
Werwitzke, Sonja, Aurélie Goyenvalle, Annemieke Aartsma‐Rus, et al.. (2020). Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B. PLoS Genetics. 16(4). e1008690–e1008690. 5 indexed citations
13.
Tiede, Andreas, Paul Giangrande, Jerome Teitel, et al.. (2019). Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statement. Haemophilia. 25(6). 969–978. 27 indexed citations
14.
Holstein, Katharina, Paul Knöbl, Christiane Dobbelstein, et al.. (2017). Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study. Blood. 130. 22–22. 2 indexed citations
15.
16.
Werwitzke, Sonja, Ulrich Geisen, Ulrike Nowak‐Göttl, et al.. (2016). Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH‐AH 01/2010 study. Journal of Thrombosis and Haemostasis. 14(5). 940–947. 42 indexed citations
17.
18.
Tiede, Andreas. (2012). Diagnosis and treatment of acquired von Willebrand syndrome. Thrombosis Research. 130. S2–S6. 68 indexed citations
19.
Tiede, Andreas, Jacob H. Rand, Ulrich Budde, Arnold Ganser, & Augusto B. Federici. (2011). How I treat the acquired von Willebrand syndrome. Blood. 117(25). 6777–6785. 182 indexed citations
20.
Tait, Robert C., Don W. Shaffer, F. Baudo, et al.. (2008). Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations. Thrombosis and Haemostasis. 99(3). 616–622. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Savage Breakdown of academic impact, for papers by Walter H.A. Kahr Breakdown of academic impact, for papers by Andrew Dunbar Breakdown of academic impact, for papers by Michael J. Mant Breakdown of academic impact, for papers by Kousuke Marutsuka Breakdown of academic impact, for papers by Ansgar Schulz Breakdown of academic impact, for papers by Mauro Di Ianni Breakdown of academic impact, for papers by Mitsuhiko Sugimoto Breakdown of academic impact, for papers by Masahiro Masuya Breakdown of academic impact, for papers by Dagmar Dilloo
Rankless by CCL
2026